secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001567264-26-000014
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics regains Nasdaq minimum bid price compliance
------------------------------------------------------------------

- Nasdaq confirmed compliance with $1.00 minimum bid price after 10 consecutive business days (Feb 19–Mar 4, 2026).
- Prior deficiency notice issued June 2025; extension granted until June 1, 2026; matter now closed.
- Late-stage clinical biotech focused on intratumoral cancer therapies using proprietary non-covalent conjugation technology.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000014/0001567264-26-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000014/intensity-20260305.htm
  HTML page:      https://secwatch.observer/filing/0001567264-26-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer